Trending NewsTrending NewsMost-Upgraded StocksMost-UpgradedNYSE:HUM Humana (HUM) Stock Price, News & Analysis $380.60 -5.18 (-1.34%) Closing price 03:59 PM EasternExtended Trading$381.96 +1.36 (+0.36%) As of 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Humana Stock (NYSE:HUM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Humana alerts:Sign Up Key Stats Today's Range$373.17▼$393.4550-Day Range$371.93▼$461.8652-Week Range$163.11▼$462.87Volume1.94 million shsAverage Volume1.67 million shsMarket Capitalization$45.71 billionP/E Ratio37.02Dividend Yield0.93%Price Target$489.35Consensus RatingModerate Buy Company Overview Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location. Humana was founded in 1961 as a nursing home company and later expanded into health insurance. Headquartered in Louisville, Kentucky, it has developed a business focused primarily on serving older adults and people enrolled in government-sponsored health programs.AI Generated. May Contain Errors. Read More Humana Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks93rd Percentile Overall ScoreHUM MarketRank™: 4.64412326152 of 5 starsHumana scored higher than 93% of companies evaluated by MarketBeat, and ranked 29th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingHumana has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 22 buy ratings, 8 hold ratings, and 2 sell ratings.Upside PotentialHumana has a consensus price target of $489.35, representing about 29.0% upside from its current price of $379.45.Amount of Analyst CoverageHumana has been the subject of 25 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth78.05% Earnings GrowthEarnings for Humana are expected to grow by 78.05% in the coming year, from $9.66 to $17.20 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 36.89, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.70.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 36.89, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 32.83.Price to Earnings Growth RatioHumana has a PEG Ratio of 2.11. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 2.41. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.32% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 2.15, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently decreased by 24.16%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldHumana has a dividend yield of 0.80%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 34.44%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 20.58% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. News and Social Media2.1 / 5News Sentiment0.37 News SentimentHumana has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 27 news articles for Humana this week, compared to 10 articles on an average week.Search InterestOnly 16 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Humana insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,384,006.00 in company stock.Percentage Held by Insiders0.20% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. Receive HUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HUM Stock News HeadlinesHumana: The Proposed CRUSH Rule Creates A Buying Opportunity1 hour ago | seekingalpha.comHumana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Humana (HUM)1 hour ago | prnewswire.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.November 19 at 1:00 AM | Behind the Markets (Ad)Should I Buy Humana Stock Now?November 19 at 10:15 AM | finance.yahoo.comWhy Is Humana Stock Falling?November 19 at 10:15 AM | finance.yahoo.comHumana (HUM) Stock Trending After Hours as CMS Proposes $90B Medicare Anti-Fraud RuleNovember 18 at 11:51 PM | benzinga.comHumana drops 9% on proposed Medicare fraud crackdownNovember 18 at 1:48 PM | seekingalpha.comMedicare Overpayment Rule Could Be A Big Test For Humana Stock (HUM)November 18 at 1:48 PM | finance.yahoo.comSee More Headlines HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $256.35 at the start of the year. Since then, HUM stock has increased by 48.0% and is now trading at $379.4480. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) issued its quarterly earnings data on Friday, November, 6th. The insurance provider reported ($0.70) EPS for the quarter, topping the consensus estimate of ($1.00) by $0.30. The firm's revenue was up 26.1% on a year-over-year basis. Read the conference call transcript. Does Humana have any subsidiaries? Humana subsidiaries include Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others. Who are Humana's major shareholders? Top institutional investors of Humana include Dodge & Cox (8.52%), State Street Corp (4.62%), Pzena Investment Management LLC (3.04%) and Assenagon Asset Management S.A. (1.05%). Insiders that own company stock include Joseph C Ventura, Sanjay K Shetty, Timothy S Huval and Jorge S Mesquita. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Salesforce (CRM), Visa (V), Boeing (BA), Tesla (TSLA) and Netflix (NFLX). Company Calendar Record date for 11/27 Dividend10/30/2026Ex-Dividend for 11/27 Dividend10/30/2026Last Earnings11/06/2026Today11/19/2026Dividend Payable11/27/2026Investor update12/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 HUM's financial health is in the Green zone, according to TradeSmith. HUM has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryManaged Healthcare Current SymbolNYSE:HUM CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,060Year Founded1961Price Target and Rating Average Price Target for Humana$489.35 High Price Target$602.00 Low Price Target$195.00 Potential Upside/Downside+28.6%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage33 Analysts Profitability EPS (Trailing Twelve Months)$10.28 Trailing P/E Ratio37.02 Forward P/E Ratio22.13 P/E Growth2.11Net Income$1.19 billion Net Margins0.81% Pretax Margin1.14% Return on Equity8.50% Return on Assets2.90% Debt Debt-to-Equity Ratio0.61 Current Ratio1.65 Quick Ratio1.65 Sales & Book Value Annual Sales$129.66 billion Price / Sales0.35 Cash Flow$20.66 per share Price / Cash Flow18.42 Book Value$157.26 per share Price / Book2.42Miscellaneous Outstanding Shares120,100,000Free Float119,863,000Market Cap$45.71 billion OptionableOptionable Beta0.65 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NYSE:HUM) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humana Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.